Axil Brands, Inc. (AXIL) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
AXIL currently has 6.8M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 16.14% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 08, 2026 |
10-Q filing | 6.8M shares outstanding |
6.8M | 0 |
| Jan 08, 2026 |
10-Q filing | 6.7M shares outstanding |
6.7M | 0 |
| Oct 07, 2025 |
10-Q filing | 6.6M shares outstanding |
6.6M | 0 |
| Aug 21, 2025 |
10-K filing | 6.4M shares outstanding |
6.4M | 0 |
| Apr 08, 2025 |
10-Q filing | 6.5M shares outstanding |
6.5M | 0 |
| Jan 08, 2025 |
10-Q filing | 6.5M shares outstanding |
6.5M | 0 |
| Oct 10, 2024 |
10-Q filing | 6.2M shares outstanding |
6.2M | 0 |
| Aug 15, 2024 |
10-K filing | 5.9M shares outstanding |
5.9M | 0 |
| Apr 09, 2024 |
10-Q filing | 5.9M shares outstanding |
5.9M | 0 |
| Mar 11, 2024 |
8-K filing: AXIL Brands, Inc. entered into repurchase agreements with stockholders to purchase 207,748,250 shares of Series A Preferred Stock (equivalent to approximately 10,387,413 shares of common stock on an as converted basis) for $1,246,489.50. ($1.25M proceeds) |
5.9M | 0 |
| Jan 16, 2024 |
Stock Split
8-K filing: Stock split 1-for-20 | Outstanding: 117,076,949 → 5,853,847 |
5.9M | 0 |
| Jan 04, 2024 |
10-Q filing | 117.1M shares outstanding |
120M | 0 |
| Oct 12, 2023 |
10-Q filing | 117.1M shares outstanding |
120M | 0 |
| Aug 21, 2023 |
10-K filing | 112.9M shares outstanding |
110M | 0 |
| Apr 12, 2023 |
10-Q filing | 117.0M shares outstanding |
120M | 0 |
| Mar 03, 2023 |
8-K filing: Reviv3 Procare Company issued 1,947,175 shares of common stock at $0.23 per share for gross proceeds of $447,850.25 in a private placement. After the transaction, the number of shares outstanding was 117,076,949. ($0.45M proceeds) |
120M | 0 |
| Jan 10, 2023 |
10-Q filing | 115.2M shares outstanding |
120M | 0 |
| Oct 12, 2022 |
10-Q filing | 115.1M shares outstanding |
120M | 0 |
| Aug 25, 2022 |
10-K filing | 115.0M shares outstanding |
110M | 0 |
| May 05, 2022 |
8-K filing: Reviv3 Procare Company entered into an Asset Purchase Agreement to acquire the hearing protection and ear bud business of Axil & Associated Brands Corp. for 73,183,893 shares of common stock and 250,000,000 shares of Series A Preferred Stock, and will effectuate a 5-to-1 reverse stock split of its outstanding common stock within 90 days following the closing of the Acquisition. ($33.32M proceeds) |
42M | 0 |
| Apr 11, 2022 |
10-Q filing | 41.9M shares outstanding |
42M | 0 |
| Jan 13, 2022 |
10-Q filing | 41.9M shares outstanding |
42M | 0 |
| Oct 13, 2021 |
10-Q filing | 41.9M shares outstanding |
42M | 0 |
| Aug 30, 2021 |
10-K filing | 41.9M shares outstanding |
42M | 0 |
| Apr 14, 2021 |
10-Q filing | 41.3M shares outstanding |
41M | 0 |
| Aug 21, 2020 |
10-K filing | 41.3M shares outstanding |
41M | 0 |
| Jan 07, 2020 |
10-Q filing | 41.3M shares outstanding |
41M | 0 |